The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemotherapy plus anti-PD-1 or anti-PD-L1 in advanced PD-L1–negative squamous cell lung carcinoma: A systematic review and meta-analysis.
 
Nicolas Peruzzo
No Relationships to Disclose
 
Gabriel Lenz
No Relationships to Disclose
 
Ted Akhiwu
No Relationships to Disclose
 
Mariah Malak Bilalaga
No Relationships to Disclose
 
Greeshma Nihitha Gaddipati
No Relationships to Disclose
 
Nathália Luisy Farias Müller
No Relationships to Disclose
 
Jincong Freeman
No Relationships to Disclose
 
Fernando Venero
Speakers' Bureau - AstraZeneca
Research Funding - Amgen - Local PI
 
Marcelo Corassa
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb Brazil; Janssen; Lilly; MSD; Novartis; Pfizer; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Takeda
Travel, Accommodations, Expenses - MSD
 
Andrés Cardona Zorrilla
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Celldex; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Lilly; Merck Sharp & Dohme; MSD; Novartis; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Merck Sharp & Dohme; Roche
 
Joshua Reuss
Honoraria - Merck
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Bristol-Myers Squibb; Catalym; Daiichi Sankyo; Gilead Sciences; Janssen; Lilly; Merck; Novocure; Pfizer; Regeneron; Seagen; Signatera; Summit Therapeutics
Research Funding - Arcus Biosciences (Inst); Exelixis (Inst); Genentech/Roche (Inst); Nuvalent, Inc. (Inst); Verastem (Inst)
 
Bruna Pellini
Employment - H. Lee Moffitt Cancer Center and Research Institute
Honoraria - AstraZeneca; Foundation Medicine; Gilead Sciences; Merck; Regeneron
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Roche; Catalyst Pharmaceuticals; Catalyst Pharmaceuticals; Foundation Medicine; Gilead Sciences; Illumina; Merus; oncohost; Regeneron
Research Funding - Bristol Myers Squibb Foundation (Inst); Bristol-Myers Squibb; Moffitt Cancer Center (Inst); National Cancer Institute (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Gilead Sciences; MSD; Regeneron